<List><item><source>MED</source><extId>29163783</extId><pmcid>PMC5685704</pmcid><annotations><annotation><prefix>ic blocking antibodies (</prefix><exact>NCT01968109</exact><postfix>; NCT02817633). </postfix><tags><tag><name>NCT01968109</name><uri>http://identifiers.org/clinicaltrials/NCT01968109</uri></tag></tags><id>http://europepmc.org/articles/PMC5685704#europepmc-1a16e41c81ac8396bbf46b59fc5e04b7</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ic blocking antibodies (NCT01968109; </prefix><exact>NCT02817633</exact><postfix>). </postfix><tags><tag><name>NCT02817633</name><uri>http://identifiers.org/clinicaltrials/NCT02817633</uri></tag></tags><id>http://europepmc.org/articles/PMC5685704#europepmc-568c12230a46321ec9e344a210ac6f9b</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix> types are ongoing (</prefix><exact>NCT02817633</exact><postfix>; NCT02608268; NCT01</postfix><tags><tag><name>NCT02817633</name><uri>http://identifiers.org/clinicaltrials/NCT02817633</uri></tag></tags><id>http://europepmc.org/articles/PMC5685704#europepmc-21d5767916dafc3ca06cc2eee44e1dc4</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>going (NCT02817633; </prefix><exact>NCT02608268</exact><postfix>; NCT01968109; NCT03</postfix><tags><tag><name>NCT02608268</name><uri>http://identifiers.org/clinicaltrials/NCT02608268</uri></tag></tags><id>http://europepmc.org/articles/PMC5685704#europepmc-3f6e7beb5aac6a7a20cbc814e08c7c80</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>T02817633; NCT02608268; </prefix><exact>NCT01968109</exact><postfix>; NCT03005782). </postfix><tags><tag><name>NCT01968109</name><uri>http://identifiers.org/clinicaltrials/NCT01968109</uri></tag></tags><id>http://europepmc.org/articles/PMC5685704#europepmc-7ad657417c3ea6675d4a09d509171ff2</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>T02817633; NCT02608268; NCT01968109; </prefix><exact>NCT03005782</exact><postfix>). </postfix><tags><tag><name>NCT03005782</name><uri>http://identifiers.org/clinicaltrials/NCT03005782</uri></tag></tags><id>http://europepmc.org/articles/PMC5685704#europepmc-e32fdf00cffa8b28e0538d42197a8e74</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>